NPs Basic Information

Name
Kojic acid
Molecular Formula C6H6O4
IUPAC Name*
5-hydroxy-2-(hydroxymethyl)pyran-4-one
SMILES
C1=C(OC=C(C1=O)O)CO
InChI
InChI=1S/C6H6O4/c7-2-4-1-5(8)6(9)3-10-4/h1,3,7,9H,2H2
InChIKey
BEJNERDRQOWKJM-UHFFFAOYSA-N
Synonyms
kojic acid; 501-30-4; 5-Hydroxy-2-(hydroxymethyl)-4H-pyran-4-one; 5-Hydroxy-2-(hydroxymethyl)-4-pyrone; 5-hydroxy-2-(hydroxymethyl)pyran-4-one; 5-Hydroxy-2-hydroxymethyl-4-pyrone; 4H-PYRAN-4-ONE, 5-HYDROXY-2-(HYDROXYMETHYL)-; acido kojico; 2-Hydroxymethyl-5-hydroxy-gamma-pyrone; 2-(Hydroxymethyl)-5-hydroxy-4H-pyran-4-one; MFCD00006580; 5-Hydroxy-2-hydroxymethyl-4H-4-pyranone; 5-Hydroxy-2-hydroxymethyl-pyran-4-one; 5-Hydroxy-2-hydroxymethyl-4H-pyran-4-one; Pyran-4-one, 5-hydroxy-2-(hydroxymethyl); CHEMBL287556; 123712-78-7; CHEBI:43572; NSC1942; 6K23F1TT52; NSC-1942; NCGC00017325-03; NCGC00017325-06; DSSTox_CID_20236; DSSTox_RID_79455; DSSTox_GSID_40236; CAS-501-30-4; CCRIS 4131; NSC 1942; EINECS 207-922-4; BRN 0120895; Kojisaeure; UNII-6K23F1TT52; AI3-02549; HSDB 7664; Spectrum_000191; KOJIC ACID [MI]; Spectrum2_001828; Spectrum3_001704; Spectrum4_000571; Spectrum5_001085; Natural Kojic Acid Powder; KOJIC ACID [HSDB]; KOJIC ACID [IARC]; KOJIC ACID [INCI]; Kojic Acid Dipalmitate 5kg; KOJIC ACID [MART.]; Oprea1_038773; SCHEMBL36895; BSPBio_003288; KBioGR_001002; KBioSS_000671; KOJIC ACID [WHO-DD]; 5-18-02-00516 (Beilstein Handbook Reference); BIDD:ER0501; DivK1c_000923; SPBio_001875; Kojic acid, analytical standard; MEGxm0_000388; WLN: T6O DVJ B1Q EQ; DTXSID2040236; ACon1_000622; BEJNERDRQOWKJM-UHFFFAOYSA-; HMS502O05; KBio1_000923; KBio2_000671; KBio2_003239; KBio2_005807; KBio3_002508; NINDS_000923; HMS3604L04; KUC106760N; TNP00261; 2-Hydroxymethyl-5-hydroxy-?-pyrone; 2-Hydroxymethyl-5-Hydroxy-G-Pyrone; Tox21_110814; Tox21_113449; BBL010645; BDBM50031467; CCG-38458; s5174; STK801688; ZINC13831818; AKOS000120649; Tox21_110814_1; 5-Hydroxy-2-hydroxymethyl-I(3)-pyron; DB01759; HY-W050154; IDI1_000923; SMP1_000171; NCGC00017325-01; NCGC00017325-02; NCGC00017325-04; NCGC00017325-05; NCGC00017325-10; NCGC00142361-01; NCGC00168903-01; NCGC00168903-02; NCGC00181145-01; AC-11658; AS-11648; Kojic acid, purum, >=98.0% (HPLC); KSC-11-228-2; SY018009; 2-HYDROXYMETHYL-5-HYDROXY-4-PYRONE; 2-Hydroxymethyl-5-hydroxy-4H-pyran-4-one; CS-0032701; FT-0627581; K0010; K0012; EN300-20919; 01K304; C91105; K-7000; 2-HYDROXYMETHYL-5-HYDROXY-.GAMMA.-PYRONE; Q416285; SR-01000945134; SR-01000945134-1; C65A72E0-0E46-4AF4-AA68-178ECA2E5FCC; F0001-1307; Z104484860
CAS 501-30-4
PubChem CID 3840
ChEMBL ID CHEMBL287556
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Organoheterocyclic compou
      • Class: Pyrans
        • Subclass: Pyranones and derivatives
          • Direct Parent: Pyranones and derivatives

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 142.11 ALogp: -0.9
HBD: 2 HBA: 4
Rotatable Bonds: 1 Lipinski's rule of five: Accepted
Polar Surface Area: 66.8 Aromatic Rings: 1
Heavy Atoms: 10 QED Weighted: 0.589

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -4.591 MDCK Permeability: 0.00006400
Pgp-inhibitor: 0 Pgp-substrate: 0.348
Human Intestinal Absorption (HIA): 0.013 20% Bioavailability (F20%): 0.176
30% Bioavailability (F30%): 0.93

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.082 Plasma Protein Binding (PPB): 53.66%
Volume Distribution (VD): 0.665 Fu: 69.76%

ADMET: Metabolism

CYP1A2-inhibitor: 0.236 CYP1A2-substrate: 0.137
CYP2C19-inhibitor: 0.036 CYP2C19-substrate: 0.064
CYP2C9-inhibitor: 0.012 CYP2C9-substrate: 0.476
CYP2D6-inhibitor: 0.01 CYP2D6-substrate: 0.505
CYP3A4-inhibitor: 0.007 CYP3A4-substrate: 0.128

ADMET: Excretion

Clearance (CL): 9.066 Half-life (T1/2): 0.888

ADMET: Toxicity

hERG Blockers: 0.058 Human Hepatotoxicity (H-HT): 0.11
Drug-inuced Liver Injury (DILI): 0.387 AMES Toxicity: 0.028
Rat Oral Acute Toxicity: 0.2 Maximum Recommended Daily Dose: 0.013
Skin Sensitization: 0.535 Carcinogencity: 0.722
Eye Corrosion: 0.019 Eye Irritation: 0.884
Respiratory Toxicity: 0.165
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC006095 0.583 D01WJL 0.244
ENC002506 0.543 D0C4YC 0.244
ENC002334 0.500 D0T7OW 0.239
ENC005612 0.457 D07AHW 0.234
ENC006096 0.442 D0N0OU 0.233
ENC004401 0.392 D08HVR 0.231
ENC002730 0.388 D07MOX 0.229
ENC001951 0.360 D0BA6T 0.222
ENC004766 0.348 D02ZJI 0.220
ENC005611 0.340 D0K5CB 0.220
*Note: the compound similarity was calculated by RDKIT.